The exact cause of pancreatic neuroendocrine tumors (PNETs) is not yet known, but there are some factors that may increase the risk of developing these tumors. Here are some known risk factors:
- Family history: People with a family history of PNETs or other types of neuroendocrine tumors may be at increased risk of developing PNETs themselves.
- Genetic syndromes: Some genetic syndromes, such as multiple endocrine neoplasia type 1 (MEN1) and von Hippel-Lindau syndrome (VHL), are associated with an increased risk of developing PNETs.
- Age: PNETs are more common in older adults.
- Gender: Women are more likely than men to develop PNETs.
- Smoking: Smoking is a known risk factor for pancreatic cancer, but it is not clear if it also increases the risk of PNETs.
- Obesity: Obesity has been associated with an increased risk of developing some types of cancer, including pancreatic cancer, but it is not clear if it also increases the risk of PNETs.
It’s important to note that having one or more of these risk factors does not necessarily mean that a person will develop PNETs, and some people with PNETs may not have any known risk factors. If you are concerned about your risk of developing PNETs, it’s best to speak with your healthcare provider.
Genetic testing for pancreatic neuroendocrine tumors (PNETs) may be recommended for individuals who have a personal or family history of PNETs or other neuroendocrine tumors, or for those who have certain genetic syndromes that are associated with an increased risk of developing PNETs. Here are some situations in which genetic testing for PNETs may be recommended:
- Personal history of PNETs: If a person has been diagnosed with a PNET, genetic testing may be recommended to identify any underlying genetic mutations that may have contributed to the development of the tumor.
- Family history of PNETs or other neuroendocrine tumors: If multiple members of a family have been diagnosed with PNETs or other neuroendocrine tumors, genetic testing may be recommended to identify any inherited genetic mutations that may increase the risk of developing these tumors.
- Genetic syndromes associated with PNETs: If a person has been diagnosed with a genetic syndrome that is known to increase the risk of developing PNETs, genetic testing may be recommended to identify any specific genetic mutations associated with the syndrome.
- Unexplained hypercalcemia or hyperparathyroidism: PNETs may be associated with hypercalcemia or hyperparathyroidism, which may be the first sign of a PNET. If a person has unexplained hypercalcemia or hyperparathyroidism, genetic testing may be recommended to identify any underlying genetic mutations that may be causing these symptoms.
It’s important to note that genetic testing is not recommended for everyone with a personal or family history of PNETs, and that the decision to undergo genetic testing should be made in consultation with a healthcare provider who is experienced in the management of PNETs and genetic syndromes.